These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 20864366)

  • 1. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
    Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
    Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.
    Huang HC; Hu CH; Tang MC; Wang WS; Chen PM; Su Y
    Oncogene; 2007 Apr; 26(19):2781-90. PubMed ID: 17072345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin β4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway.
    Piao Z; Hong CS; Jung MR; Choi C; Park YK
    Biochem Biophys Res Commun; 2014 Sep; 452(3):858-64. PubMed ID: 25218472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma.
    Hong KO; Lee JI; Hong SP; Hong SD
    Amino Acids; 2016 Jan; 48(1):117-27. PubMed ID: 26276576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of thymosin β4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients.
    Wang ZY; Zhang W; Yang JJ; Song DK; Wei JX; Gao S
    Neoplasma; 2016; 63(6):991-998. PubMed ID: 27596300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
    Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
    Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
    Wu CL; Ho JY; Chou SC; Yu DS
    Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.
    Guo C; Zhu K; Sun W; Yang B; Gu W; Luo J; Peng B; Zheng J
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1226-31. PubMed ID: 24393848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin-linked kinase regulates cadherin switch in bladder cancer.
    Gil D; Ciołczyk-Wierzbicka D; Dulińska-Litewka J; Laidler P
    Tumour Biol; 2016 Nov; 37(11):15185-15191. PubMed ID: 27683053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual role of TGFBR3 in bladder cancer.
    Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
    Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin β4 promotes hepatoblastoma metastasis via the induction of epithelial-mesenchymal transition.
    Fu X; Cui P; Chen F; Xu J; Gong L; Jiang L; Zhang D; Xiao Y
    Mol Med Rep; 2015 Jul; 12(1):127-32. PubMed ID: 25695679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
    Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
    Liu Y; Qin Z; Yang K; Liu R; Xu Y
    Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.
    Liang PY; Li HY; Zhou ZY; Jin YX; Wang SX; Peng XH; Ou SJ
    Tumour Biol; 2013 Jun; 34(3):1783-91. PubMed ID: 23483488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.